Hepatocellular Carcinoma Market Gains Momentum as Immunotherapy and Targeted Treatments Redefine Care | CI Insights
Hepatocellular carcinoma market transforms as immunotherapies, targeted drugs, and novel combinations shift standards and spark new competition. AUSTIN, TX, UNITED STATES, June 4, 2025 /EINPresswire.com/ -- Hepatocellular carcinoma (HCC), the most …